Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways

The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS pharmacology & translational science 2023-12, Vol.6 (12), p.1790-1800
1. Verfasser: Voss, Jan Hendrik
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1800
container_issue 12
container_start_page 1790
container_title ACS pharmacology & translational science
container_volume 6
creator Voss, Jan Hendrik
description The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin, whose application can be tedious and is restricted to the inhibition of Gα proteins and activation of Gα proteins, respectively. The breakthrough discovery and characterization of YM and FR rendered the closely related Gα , Gα , and Gα proteins amenable to pharmacological inhibition, and since then, both compounds have become widely used in molecular pharmacology and were also proven to be efficacious in animal models of disease. In the past years, both YM and FR were thoroughly characterized and have substantially contributed to an improved understanding of Gα signaling on a molecular and cellular level. Yet, the possibilities to interrogate Gα signaling in complex systems have only been exploited in a very limited number of studies, whose promising initial results warrant further application of YM and FR in basic and translational research. As both compounds have become commercially available as of late, this review focuses on their application in cell-based assays and in vivo systems, highlighting their qualities as tool compounds and providing instructions for their use.
doi_str_mv 10.1021/acsptsci.3c00214
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10714435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2902952197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-3369504875fd3473602853142c0f028dd08bd8277af89c214ebf8a3c2118c17e3</originalsourceid><addsrcrecordid>eNpVUU1PJCEQJWY3alzvngzHvbQW0Ah4MWayuiYajR8HT4QBesR0Q9swbvxZ-0f2Ny3G0eipXlW9elWph9AOgT0ClOwbm8eSbdhjFmrerqFNygVvFAH57RPeQNs5P0LlADCiYB1tMAmKSSY20fO1t2kYfHTe4duUejxLw5iW0eVDfDyOfbCmhBRx6vD9RUN5KxVgEx0-uVZVjytcEj6LxU9TWpji8em_v_hpnxDcXHgXasXhm7CIpg9xga9MefhjXvIP9L0zffbbq7iF7k5-3c5-N-eXp2ez4_PGMiVKw9iB4tBKwTvHWsEOgErOSEstdBU6B3LuJBXCdFLZ-gM_76RhFRFpifBsCx296Y7L-eCd9bFMptfjFAYzvehkgv7aieFBL9KzJiBI2zJeFX6uFKb0tPS56CFk6_veRJ-WWVMFVHFKlKhUeKPaKeU8-e5jDwH9apl-t0yvLKsju5_v-xh4N4j9ByJWknM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2902952197</pqid></control><display><type>article</type><title>Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways</title><source>ACS Journals: American Chemical Society Web Editions</source><source>NCBI_PubMed Central(免费)</source><creator>Voss, Jan Hendrik</creator><creatorcontrib>Voss, Jan Hendrik</creatorcontrib><description>The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin, whose application can be tedious and is restricted to the inhibition of Gα proteins and activation of Gα proteins, respectively. The breakthrough discovery and characterization of YM and FR rendered the closely related Gα , Gα , and Gα proteins amenable to pharmacological inhibition, and since then, both compounds have become widely used in molecular pharmacology and were also proven to be efficacious in animal models of disease. In the past years, both YM and FR were thoroughly characterized and have substantially contributed to an improved understanding of Gα signaling on a molecular and cellular level. Yet, the possibilities to interrogate Gα signaling in complex systems have only been exploited in a very limited number of studies, whose promising initial results warrant further application of YM and FR in basic and translational research. As both compounds have become commercially available as of late, this review focuses on their application in cell-based assays and in vivo systems, highlighting their qualities as tool compounds and providing instructions for their use.</description><identifier>ISSN: 2575-9108</identifier><identifier>EISSN: 2575-9108</identifier><identifier>DOI: 10.1021/acsptsci.3c00214</identifier><identifier>PMID: 38093837</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Review</subject><ispartof>ACS pharmacology &amp; translational science, 2023-12, Vol.6 (12), p.1790-1800</ispartof><rights>2023 The Author. Published by American Chemical Society.</rights><rights>2023 The Author. Published by American Chemical Society 2023 The Author</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-3369504875fd3473602853142c0f028dd08bd8277af89c214ebf8a3c2118c17e3</citedby><cites>FETCH-LOGICAL-c397t-3369504875fd3473602853142c0f028dd08bd8277af89c214ebf8a3c2118c17e3</cites><orcidid>0000-0003-0595-4607</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714435/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714435/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,2765,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38093837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Voss, Jan Hendrik</creatorcontrib><title>Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways</title><title>ACS pharmacology &amp; translational science</title><addtitle>ACS Pharmacol Transl Sci</addtitle><description>The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin, whose application can be tedious and is restricted to the inhibition of Gα proteins and activation of Gα proteins, respectively. The breakthrough discovery and characterization of YM and FR rendered the closely related Gα , Gα , and Gα proteins amenable to pharmacological inhibition, and since then, both compounds have become widely used in molecular pharmacology and were also proven to be efficacious in animal models of disease. In the past years, both YM and FR were thoroughly characterized and have substantially contributed to an improved understanding of Gα signaling on a molecular and cellular level. Yet, the possibilities to interrogate Gα signaling in complex systems have only been exploited in a very limited number of studies, whose promising initial results warrant further application of YM and FR in basic and translational research. As both compounds have become commercially available as of late, this review focuses on their application in cell-based assays and in vivo systems, highlighting their qualities as tool compounds and providing instructions for their use.</description><subject>Review</subject><issn>2575-9108</issn><issn>2575-9108</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVUU1PJCEQJWY3alzvngzHvbQW0Ah4MWayuiYajR8HT4QBesR0Q9swbvxZ-0f2Ny3G0eipXlW9elWph9AOgT0ClOwbm8eSbdhjFmrerqFNygVvFAH57RPeQNs5P0LlADCiYB1tMAmKSSY20fO1t2kYfHTe4duUejxLw5iW0eVDfDyOfbCmhBRx6vD9RUN5KxVgEx0-uVZVjytcEj6LxU9TWpji8em_v_hpnxDcXHgXasXhm7CIpg9xga9MefhjXvIP9L0zffbbq7iF7k5-3c5-N-eXp2ez4_PGMiVKw9iB4tBKwTvHWsEOgErOSEstdBU6B3LuJBXCdFLZ-gM_76RhFRFpifBsCx296Y7L-eCd9bFMptfjFAYzvehkgv7aieFBL9KzJiBI2zJeFX6uFKb0tPS56CFk6_veRJ-WWVMFVHFKlKhUeKPaKeU8-e5jDwH9apl-t0yvLKsju5_v-xh4N4j9ByJWknM</recordid><startdate>20231208</startdate><enddate>20231208</enddate><creator>Voss, Jan Hendrik</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0595-4607</orcidid></search><sort><creationdate>20231208</creationdate><title>Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways</title><author>Voss, Jan Hendrik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-3369504875fd3473602853142c0f028dd08bd8277af89c214ebf8a3c2118c17e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Voss, Jan Hendrik</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS pharmacology &amp; translational science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Voss, Jan Hendrik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways</atitle><jtitle>ACS pharmacology &amp; translational science</jtitle><addtitle>ACS Pharmacol Transl Sci</addtitle><date>2023-12-08</date><risdate>2023</risdate><volume>6</volume><issue>12</issue><spage>1790</spage><epage>1800</epage><pages>1790-1800</pages><issn>2575-9108</issn><eissn>2575-9108</eissn><abstract>The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin, whose application can be tedious and is restricted to the inhibition of Gα proteins and activation of Gα proteins, respectively. The breakthrough discovery and characterization of YM and FR rendered the closely related Gα , Gα , and Gα proteins amenable to pharmacological inhibition, and since then, both compounds have become widely used in molecular pharmacology and were also proven to be efficacious in animal models of disease. In the past years, both YM and FR were thoroughly characterized and have substantially contributed to an improved understanding of Gα signaling on a molecular and cellular level. Yet, the possibilities to interrogate Gα signaling in complex systems have only been exploited in a very limited number of studies, whose promising initial results warrant further application of YM and FR in basic and translational research. As both compounds have become commercially available as of late, this review focuses on their application in cell-based assays and in vivo systems, highlighting their qualities as tool compounds and providing instructions for their use.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>38093837</pmid><doi>10.1021/acsptsci.3c00214</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-0595-4607</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2575-9108
ispartof ACS pharmacology & translational science, 2023-12, Vol.6 (12), p.1790-1800
issn 2575-9108
2575-9108
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10714435
source ACS Journals: American Chemical Society Web Editions; NCBI_PubMed Central(免费)
subjects Review
title Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A22%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommended%20Tool%20Compounds:%20Application%20of%20YM-254890%20and%20FR900359%20to%20Interrogate%20G%CE%B1%20q/11%20-Mediated%20Signaling%20Pathways&rft.jtitle=ACS%20pharmacology%20&%20translational%20science&rft.au=Voss,%20Jan%20Hendrik&rft.date=2023-12-08&rft.volume=6&rft.issue=12&rft.spage=1790&rft.epage=1800&rft.pages=1790-1800&rft.issn=2575-9108&rft.eissn=2575-9108&rft_id=info:doi/10.1021/acsptsci.3c00214&rft_dat=%3Cproquest_pubme%3E2902952197%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2902952197&rft_id=info:pmid/38093837&rfr_iscdi=true